MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Drops

国药准字H20213695

September 1, 2021

Drug Information

盐酸左西替利嗪口服滴剂

口服溶液剂

20ml:100mg

化学药品

September 1, 2021

Company Information

Applicant Company

厦门市海沧区后祥路71号5号楼第5层之一

Manufacturing Company

福建省厦门市海沧区新美路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服滴剂 - NMPA 批准文号 | MedPath